Hotspots and Emerging Trends in JAK Inhibitor Therapy for Vitiligo: A Bibliometric Analysis (2015-2025). (PubMed, J Inflamm Res) - Sep 28, 2026 - "According to keyword burst detection, tofacitinib and chemokine-related research have emerged as the latest focal points...This article summarizes the current research landscape and emerging advances in JAK inhibitors therapy for vitiligo. JAK inhibitor research in vitiligo has undergone a paradigm shift from non-specific immunosuppression to targeted blockade of the IFN-γ-CXCL9/10 inflammatory axis, providing a valuable reference for future research in this field."
Journal • Dermatology • Immunology • Vitiligo • CXCL9 • IFNG
|
|
Anqi Xie; Huimin He; Jindi Feng; Lu Lu; Lu Yang; Shiyu Zhang; Tao Wang; Yubin Peng; Yuehua Liu
|